丝胺酸市场－2026-2031年预测

预计丝胺酸市场将从 2025 年的 289,058,000 美元成长到 2031 年的 401,651,000 美元，复合年增长率为 5.64%。

丝胺酸(PS) 是一种磷脂，对细胞膜功能至关重要，在脑组织中的含量尤其高。历史上，脑病变(BSE) 问题导致牛源性磷脂酰丝胺酸的供应中断，促使人们转向植物来源磷脂，主要来源是大豆卵磷脂和向日葵卵磷脂。这种转变巩固了人们对更安全、更永续替代品的偏好，使得向日葵来源的磷脂酰丝胺酸因其非基因改造 (non-GMO) 特性而价格更高。目前，磷脂酰丝氨酸市场正扩展至膳食补充剂（片剂、软胶囊和粉末）以及新兴的机能性食品和饮料领域，其核心应用集中在认知支持、压力调节和运动后恢復等方面。

全球人口老化和人们对认知能力下降的意识提升推动了PS补充剂的需求增长，这些补充剂声称可以增强老年人的记忆力和思维能力。此外，PS调节皮质醇的作用也刺激了运动营养领域对PS补充剂的需求，用于帮助年轻人运动后恢復和优化认知能力，从而进一步促进了PS市场的成长。

各国的法规结构存在显着差异。在美国，根据《膳食补充剂健康与教育法案》(DSHEA)，FDA批准的健康声明允许包含详细的认知功能通讯，并附带免责声明，这有利于膳食补充剂领域的积极营销和大规模普及。相较之下，欧盟的EFSA（欧洲食品安全局）严格审查（EC法规1924/2006）不允许发布第13.1条规定的特定声明，限制了与促进大脑健康相关的明确声明，从而将产品定位限制在一般健康促进领域。日本的特定保健用途食品(FOSHU)系统则在老龄化社会背景下利用科学证据，促进相关功效快速纳入已註册的机能性食品和膳食补充剂中。

原料价格与主要大豆和葵花籽生产国（美国、巴西、中国）卵磷脂商品价格的波动直接相关，产品则依酵素转化成本分级。高纯度（超过50%）用于高端膳食补充剂，而低浓度则用于食品强化。葵花籽卵磷脂的高价格反映了消费者对洁净标示产品的需求，但转化技术的集中（中国和北美）造成了供应链的脆弱性。温控物流对于维持磷脂质的稳定性至关重要。

膳食补充剂的使用已成为主流，主要由活跃的个人消费者推动，涵盖了从老年人记忆力增强到益智补剂和压力管理等各种需求。最终用户主要是个人，而两种细分市场推动了产品剂型的多样化：一种是面向老年人、生物有效性的软胶囊/片剂；另一种是面向注重运动表现的年轻消费者、粉末状混合剂。

从地理上看，美国处于主导地位，透过放鬆管制和直销管道支持复杂配方产品的创新。日本透过FFC註册的记忆力维护产品展现出结构性需求。德国优先考虑标籤法规下的检验纯度和植物来源。巴西致力于加强机能性食品的发展，而阿联酋则专注于符合健康生活方式的高端进口保健品。

竞争格局分为两大阵营：一是注重酵素效率和植物性原料采购的原料生产商，二是依赖临床证据和创新递送技术竞争的产品开发商。 L&P食品原料有限公司在亚洲地区大规模粉末原料供应方面展现出强大的实力。 Thorne公司则专注于医疗保健专业人士的研究管道。 Soft Gel Technologies公司专注于软胶囊封装技术，尤其致力于提高PS-DHA复合物的生物利用度。

在市场趋势方面，Thorne于2025年5月宣布成立科学顾问委员会，旨在促进科学健康和创新。同年12月，推出了“Taia”，这是一款透过临床研究训练的人工智慧健康顾问，可根据其认知功能支援产品系列提供个人化的营养补充指导。

丝胺酸市场正受益于人口结构变化、植物来源成分需求成长以及监管细分等有利因素而不断发展。市场机会主要集中在机能性食品以增强型磷脂酰丝胺酸缀合物（例如PS-DHA）和稳定粉末领域，特别是在亚太地区。然而，原材料价格波动、生产流程复杂以及功效声明不一致等挑战也不容忽视，这使得那些具备纯度控制、研发投入和遵守当地法规等专业知识的供应商更具优势。

本报告的主要优势：

• 深入分析：提供对主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
• 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略进入市场的机会。
• 市场驱动因素与未来趋势：探讨影响市场的动态因素和关键趋势及其对未来市场发展的影响。
• 可操作的建议：利用这些见解，在快速变化的环境中做出策略决策，并发现新的商机和收入来源。
• 受众广泛：对Start-Ups、研究机构、顾问公司、中小企业和大型企业都很有用且经济实惠。

它是用来做什么的？

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

研究范围：

• 2021年至2025年的历史数据和2026年至2031年的预测数据
• 成长机会、挑战、供应链前景、法规结构与趋势分析
• 竞争定位、策略和市场占有率分析
• 按业务板块和地区（包括国家）分類的收入和预测评估
• 公司概况（策略、产品、财务资讯）及主要发展动态。

目录

第一章执行摘要

第二章 市场概览

• 市场概览
• 市场定义
• 调查范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策与法规
• 策略建议

第四章 技术展望

5. 依形式分類的丝胺酸市场

• 介绍
• 粉末
• 药片
• 软胶囊

第六章 依原料分類的丝胺酸市场

• 介绍
• 鱼
• 大豆
• 向日葵
• 高丽菜

第七章 依最终用户分類的丝胺酸市场

• 介绍
• 对于个人
• 工业应用
• 製药和保健品产业

8. 各地区丝胺酸市场

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章 竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 合併、收购、协议和合作
• 竞争对手仪錶板

第十章：公司简介

• L&P Food Ingredient Co., Ltd
• Integrative Therapeutics
• Thorne
• Nature's Way Brands
• Metagenics
• COFTTEK Inc
• Laybio
• Double Wood Supplements
• Haihang Industry
• Soft Gel Technologies, Inc

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 调查方法
• 简称

Phosphatidylserine Market is projected to grow at a 5.64% CAGR, increasing from USD 289.058 million in 2025 to USD 401.651 million in 2031.

Phosphatidylserine (PS), a phospholipid integral to cell membrane function and particularly concentrated in brain tissue, has transitioned to predominantly plant-based sourcing from soy and sunflower lecithin due to historical BSE concerns eliminating animal-derived options. This shift has solidified preference for safer, sustainable alternatives, with sunflower-derived PS commanding premiums for non-GMO attributes. The market centers on cognitive support, stress modulation, and athletic recovery, manifesting in supplements (tablets, softgels, powders) and emerging functional foods/beverages.

Growth is propelled by aging global populations and heightened awareness of cognitive decline, driving demand in the supplements segment where PS is positioned for memory and thinking skill support in geriatric cohorts. Additional momentum arises from its cortisol-modulating effects, appealing to sports nutrition for post-exercise recovery and mental performance optimization among younger consumers.

Regulatory frameworks diverge significantly. In the United States, FDA Qualified Health Claims under DSHEA permit nuanced cognitive function messaging with disclaimers, fostering aggressive marketing and high-volume adoption in supplements. Conversely, EFSA's stringent review under Regulation (EC) No 1924/2006 has denied specific Article 13.1 claims, constraining explicit brain health promotion in the EU and limiting growth to general wellness positioning. Japan's Foods with Function Claims system accelerates incorporation into registered functional foods and supplements, leveraging scientific substantiation amid an aging demographic.

Raw material pricing ties directly to volatile lecithin commodities from major soybean/sunflower producers (US, Brazil, China), with enzymatic conversion costs stratifying offerings-high-purity (50%+) for premium supplements versus lower concentrations for food fortification. Sunflower PS premiums reflect clean-label demand, while supply chain vulnerabilities stem from concentrated conversion expertise in China and North America, necessitating temperature-controlled logistics for phospholipid stability.

The supplements application dominates, fueled by proactive individual consumers spanning geriatric memory support and nootropic/stress management needs. End-users are primarily individuals, with dual cohorts driving diversified formats: softgels/tablets for bioavailability in older demographics, powders for mixing in performance-oriented younger users.

Regionally, the US leads via permissive regulation and direct-to-consumer channels, supporting innovation in combination formulas. Japan exhibits structural demand through FFC-registered products targeting memory maintenance. Germany prioritizes verifiable purity and plant sourcing amid claim restrictions. Brazil leans toward functional food fortification, while the UAE focuses on premium imported supplements aligned with wellness lifestyles.

Competition bifurcates between raw ingredient producers emphasizing enzymatic efficiency and plant sourcing, and finished product formulators competing on clinical backing and delivery innovation. L&P Food Ingredient Co., Ltd. excels in large-scale Asian conversion for bulk powder supply. Thorne targets practitioner-channel supplements with research emphasis. Soft Gel Technologies, Inc. specializes in softgel encapsulation, often for PS-DHA conjugates enhancing bioavailability.

In market developments, Thorne announced the formation of a Scientific Advisory Board in May 2025 to advance scientific wellness and innovation. In December 2025, Thorne launched Taia, an AI-powered wellness advisor trained on clinical research, providing personalized supplement guidance supportive of its cognitive portfolio.

The phosphatidylserine market evolves through demographic tailwinds, plant-based imperatives, and regulatory segmentation. Opportunities center on enriched conjugates (e.g., PS-DHA) and stabilized powders for functional foods, particularly in Asia Pacific, while challenges include commodity volatility, conversion complexity, and claim disparities-favoring suppliers with purity control, research investment, and regional compliance expertise.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Phosphatidylserine Market Segmentation

• By Form
• Powder
• Tablet
• Softgels
• By Source
• Fish
• Soy
• Sunflowers
• Cabbage
• By End User
• Individuals
• Industrial Use
• Drugs and Supplement Industry
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. PHOSPHATIDYLSERINE MARKET BY FORM

• 5.1. Introduction
• 5.2. Powder
• 5.3. Tablet
• 5.4. Softgels

6. PHOSPHATIDYLSERINE MARKET BY SOURCE

• 6.1. Introduction
• 6.2. Fish
• 6.3. Soy
• 6.4. Sunflowers
• 6.5. Cabbage

7. PHOSPHATIDYLSERINE MARKET BY END USER

• 7.1. Introduction
• 7.2. Individuals
• 7.3. Industrial Use
• 7.4. Drugs and Supplement Industry

8. PHOSPHATIDYLSERINE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. L&P Food Ingredient Co., Ltd
• 10.2. Integrative Therapeutics
• 10.3. Thorne
• 10.4. Nature's Way Brands
• 10.5. Metagenics
• 10.6. COFTTEK Inc
• 10.7. Laybio
• 10.8. Double Wood Supplements
• 10.9. Haihang Industry
• 10.10. Soft Gel Technologies, Inc

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations